Explorez tous les épisodes du podcast Joe Mullings Untitled

Joe & Steve Bell discuss surgical robotics, more specifically the companies building a robot outside of the US who have begun the journey to participate in the US market. With many robots in development currently, the road to the US is critical to gaining momentum and market share. The micro and macro differences in how engineers globally approach designing a robot are already coming to light. Differentiators and solving existing problems for surgeons will be key in the race to access the US market.

Joe and Steve discuss the rapidly evolving dynamics of the soft tissue surgical robotics markets and what moves some of the current form factors and companies are committing to. 

Intuitive released the DaVinci 5 platform and it is creating a higher bar in the soft tissue surgical robotic market. Joe and Steve discuss how the table stakes for surgical robotics has been leveled up with the D5 platform. 

Tony Blauer wrote the book on the Management of Fear in Combat Sports as well as violent encounters. His body of work is even more applicable in the business world. Joe and Tony discuss how fear management and the control of our emotions can be the difference maker in success and failure. 

Steve and Joe discuss the emerging market of endovascular robotics and how it sets up to be a bigger market than soft tissue robotics and enabled by quicker development times, less cost, and more acquirers in the market. 

Joe and Mike Minogue, the recent CEO of Abiomed which was sold to Johnson & Johnson for $16 billion discuss some of the principles and the mindset of how to build high performing teams and enable success. 

In the inaugural episode of Joe Mullings Untitled, Steve Bell and Joe Mullings discuss the emerging trends, industry dynamics, the changing centers of care, and where the soft tissue surgical robotic market and technologies are likely going.